Clinical trials for Vitamin B12 or folate deficiency anaemia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Vitamin B12 or folate deficiency anaemia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Vitamin B12 or folate deficiency anaemia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Vitamin B12 or folate deficiency anaemia
Title Recruitment status Location
Testing a new stepwise strategy for the management of renal anaemia Recruiting United Kingdom
Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease. Recruiting United Kingdom
Is intravenous iron and darbepoetin more effective than oral iron in reducing blood transfusion requirements for patients undergoing cardiac surgery? Recruiting United Kingdom
A 24-week, Phase IIB, Randomized, Active-controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects With Anemia Associated With Chronic Kidney Diseases Who Are Not on Dialysis. Recruiting United Kingdom
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) Recruiting United Kingdom
Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs Recruiting United Kingdom
A Phase I/II study of Azacitidine (Vidaza®) in pediatric patients with newly diagnosed or relapsed high-grade pediatric MDS or JMML Recruiting United Kingdom
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA Recruiting United Kingdom
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency Recruiting United Kingdom
A Phase 2 Multicenter, Randomized, Open-Label , Multiple-Dose Study of Intravenous and Subcutaneous Administration of Sotatercept (ACE-011) in Subjects With End-Stage Kidney Disease on Hemodialysis Switched From Erythropoiesis Stimulating Agents With Staggered Dose Group Escalation in Part 1 Followed by a Parallel Group, Active Controlled Study of Selected Dose(s) and Regimen(s) in Part 2: To Evaluate the Pharmacokinetics, Safety, Tolerability, Efficacy, Dosing Regimen, and Pharmacodynamics of Sotatercept Recruiting United Kingdom

Page last reviewed: 16/05/2016

Next review due: 01/05/2019